Cargando…

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)

Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to significantly reduce the quality of life in severely affected patients. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Despite the large variety of treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Nast, A., Kopp, I., Augustin, M., Banditt, K. B., Boehncke, W. H., Follmann, M., Friedrich, M., Huber, M., Kahl, C., Klaus, J., Koza, J., Kreiselmaier, I., Mohr, J., Mrowietz, U., Ockenfels, H. M., Orzechowski, H. D., Prinz, J., Reich, K., Rosenbach, T., Rosumeck, S., Schlaeger, M., Schmid-Ott, G., Sebastian, M., Streit, V., Weberschock, T., Rzany, B.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1910890/
https://www.ncbi.nlm.nih.gov/pubmed/17497162
http://dx.doi.org/10.1007/s00403-007-0744-y
_version_ 1782134051341074432
author Nast, A.
Kopp, I.
Augustin, M.
Banditt, K. B.
Boehncke, W. H.
Follmann, M.
Friedrich, M.
Huber, M.
Kahl, C.
Klaus, J.
Koza, J.
Kreiselmaier, I.
Mohr, J.
Mrowietz, U.
Ockenfels, H. M.
Orzechowski, H. D.
Prinz, J.
Reich, K.
Rosenbach, T.
Rosumeck, S.
Schlaeger, M.
Schmid-Ott, G.
Sebastian, M.
Streit, V.
Weberschock, T.
Rzany, B.
author_facet Nast, A.
Kopp, I.
Augustin, M.
Banditt, K. B.
Boehncke, W. H.
Follmann, M.
Friedrich, M.
Huber, M.
Kahl, C.
Klaus, J.
Koza, J.
Kreiselmaier, I.
Mohr, J.
Mrowietz, U.
Ockenfels, H. M.
Orzechowski, H. D.
Prinz, J.
Reich, K.
Rosenbach, T.
Rosumeck, S.
Schlaeger, M.
Schmid-Ott, G.
Sebastian, M.
Streit, V.
Weberschock, T.
Rzany, B.
author_sort Nast, A.
collection PubMed
description Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to significantly reduce the quality of life in severely affected patients. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis. The guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. The short version of the guidelines reported here consist of a series of therapeutic recommendations that are based on a systematic literature search and subsequent discussion with experts in the field; they have been approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs as well as detailed information on how best to apply the treatments described (for full version, please see Nast et al., JDDG, Suppl 2:S1–S126, 2006; or http://www.psoriasis-leitlinie.de).
format Text
id pubmed-1910890
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-19108902007-07-06 German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version) Nast, A. Kopp, I. Augustin, M. Banditt, K. B. Boehncke, W. H. Follmann, M. Friedrich, M. Huber, M. Kahl, C. Klaus, J. Koza, J. Kreiselmaier, I. Mohr, J. Mrowietz, U. Ockenfels, H. M. Orzechowski, H. D. Prinz, J. Reich, K. Rosenbach, T. Rosumeck, S. Schlaeger, M. Schmid-Ott, G. Sebastian, M. Streit, V. Weberschock, T. Rzany, B. Arch Dermatol Res Review Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to significantly reduce the quality of life in severely affected patients. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis. The guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. The short version of the guidelines reported here consist of a series of therapeutic recommendations that are based on a systematic literature search and subsequent discussion with experts in the field; they have been approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs as well as detailed information on how best to apply the treatments described (for full version, please see Nast et al., JDDG, Suppl 2:S1–S126, 2006; or http://www.psoriasis-leitlinie.de). Springer-Verlag 2007-05-12 2007-06 /pmc/articles/PMC1910890/ /pubmed/17497162 http://dx.doi.org/10.1007/s00403-007-0744-y Text en © Springer-Verlag 2007
spellingShingle Review
Nast, A.
Kopp, I.
Augustin, M.
Banditt, K. B.
Boehncke, W. H.
Follmann, M.
Friedrich, M.
Huber, M.
Kahl, C.
Klaus, J.
Koza, J.
Kreiselmaier, I.
Mohr, J.
Mrowietz, U.
Ockenfels, H. M.
Orzechowski, H. D.
Prinz, J.
Reich, K.
Rosenbach, T.
Rosumeck, S.
Schlaeger, M.
Schmid-Ott, G.
Sebastian, M.
Streit, V.
Weberschock, T.
Rzany, B.
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
title German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
title_full German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
title_fullStr German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
title_full_unstemmed German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
title_short German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
title_sort german evidence-based guidelines for the treatment of psoriasis vulgaris (short version)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1910890/
https://www.ncbi.nlm.nih.gov/pubmed/17497162
http://dx.doi.org/10.1007/s00403-007-0744-y
work_keys_str_mv AT nasta germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT koppi germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT augustinm germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT bandittkb germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT boehnckewh germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT follmannm germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT friedrichm germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT huberm germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT kahlc germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT klausj germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT kozaj germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT kreiselmaieri germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT mohrj germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT mrowietzu germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT ockenfelshm germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT orzechowskihd germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT prinzj germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT reichk germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT rosenbacht germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT rosumecks germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT schlaegerm germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT schmidottg germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT sebastianm germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT streitv germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT weberschockt germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion
AT rzanyb germanevidencebasedguidelinesforthetreatmentofpsoriasisvulgarisshortversion